Evidence Hub

Headache as an extraocular manifestation of birdshot chorioretinopathy: a case series

Groothoff JD, Sohi MK, Shuman H, Hardy BW, Goodrich RC, Pocock KS

Frontiers in ophthalmology, 2026

Abstract

Birdshot chorioretinopathy (BSCR) is a type of chronic posterior uveitis with limited characterization of extraocular manifestations, including headache. We describe two HLA-A29-positive patients with BSCR who developed refractory unilateral periorbital headaches temporally associated with visual symptom onset. Headaches lateralized to the more affected eye and the patients exhibited migrainous and prominent cranial autonomic features resembling trigeminal autonomic cephalalgias (TACs) and variable responses to standard headache therapies. Together, this supports the International Classification of Headache Disorders (ICHD-3) classification as a secondary headache attributed to ocular inflammatory disease. The biological plausibility of this association is supported by trigeminal innervation of the uveal tract, providing a substrate for inflammation-driven trigeminovascular activation. Systematic studies are needed to define BSCR-associated headache prevalence, phenotype, and mechanisms and to inform diagnosis and management.

How strong is the evidence?

Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free